INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Reckitt Benckiser Group plc - RBGLY


NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of  Reckitt Benckiser Group plc ("Reckitt" or the "Company") (OTCMKTS:RBGLY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Reckitt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On March 15, 2024, an Illinois jury returned a $60 million verdict against Reckitt in a lawsuit finding that Reckitt's Mead Johnson Nutrition unit failed to adequately disclose the risks of necrotizing enterocolitis in its cow-milk-based Enfamil baby formula.  Following the verdict, Reckitt's American depositary receipt ("ADR") price fell $1.87 per ADR, or 14.05%, to close at $11.44 per ADR on March 15, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising. Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-reckitt-benckiser-group-plc---rbgly-302368183.html

SOURCE Pomerantz LLP

Aktuelle Reckitt Benckiser Aktie News

Werbung

Reckitt Benckiser Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Reckitt Benckiser nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
30.12.25 Reckitt Benckiser Neutral JP Morgan Chase & Co.
30.12.25 Reckitt Benckiser Outperform Bernstein Research
17.12.25 Reckitt Benckiser Outperform Bernstein Research
25.11.25 Reckitt Benckiser Outperform Bernstein Research
17.09.25 Reckitt Benckiser Outperform RBC Capital Markets

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.